Jennifer Burstein
Director/Board Member at STOKE THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ian Smith | M | 58 | 14 years | |
| Huw Nash | M | 57 | 10 years | |
| Adrian Krainer | M | 65 | 10 years | |
| Seth Harrison | M | 63 | 9 years | |
| David Bonita | M | 48 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | 5 years |
| John Kelley | M | 70 | 16 years | |
| Kerry Clem | M | 54 | 13 years | |
| Josh Bilenker | M | 52 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Arthur Levin | M | 70 | 9 years | |
| Isabel Aznarez | M | 52 | 10 years | |
| Arthur Tzianabos | M | 60 | 6 years | |
| Julie Smith | F | 53 | 4 years | |
| Garry Menzel | M | 59 | 4 years | |
| Edward Kaye | M | 74 | 7 years | |
| Peder K. Jensen | M | 69 | 13 years | |
| Jonathan Allan | M | - | - | |
| Steven Elms | M | 60 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Avi Z. Naider | M | 52 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| David Schenkein | M | 66 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Aftab Kherani | M | 50 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Eric Rojas | M | - | - | |
| Dawn Kalmar | F | 47 | 5 years | |
| Kristina Burow | F | 50 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Joan Wood | F | - | 5 years | |
| Shamim Ruff | F | 64 | 6 years | |
| Barry Ticho | M | 64 | 7 years | |
| Sunitha Ramamurthy | F | - | 6 years | |
| Jeffrey Engelman | M | - |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Doug Snow | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dov Goldstein | M | 56 | 2 years | |
| Jeff Randall | M | 80 | 17 years | |
| David Guyer | M | 64 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Robert Morales | M | 57 | 7 years | |
| Lauren Sabella | F | 63 | 12 years | |
| Barry Greene | M | 60 | 14 years | |
| Nancy M. Wyant | F | - | 5 years | |
| Christian Richardson | M | - | - | |
| Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Steven Harr | M | 53 | 3 years | |
| Paul Chaney | M | 66 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 10 years |
| Adrian L. Rabinowicz | M | - | 6 years | |
| Tim Mayleben | M | 63 | 4 years | |
| Robin A. Walker | M | 55 | 1 years | |
| Kent Rogers | M | 54 | - | |
| Michael Barrett | M | 81 | 2 years | |
| Brian Walter | M | - | - | |
| Todd F. Baumgartner | M | - | 5 years | |
| Michelle Huie | F | - | - | |
| Brian W. Hutchinson | M | - | 5 years | |
| Bonnie M. Pappacena | F | - | - | |
| Thomas C. Aquilina | M | - | - | |
| S. Michael Rothenberg | M | 54 | 5 years | |
| Jennifer Low | M | 54 | 2 years | |
| Rebecca R. Levine | F | - | 5 years | |
| Enrique Carrazana | M | 62 | 5 years | |
| Deborah Morosini | M | 65 | 3 years | |
| Michael Samar | M | 51 | 3 years | |
| Gene Liau | M | 69 | 4 years | |
| Charles R. Allerson | M | 56 | 2 years | |
| Meena | M | 51 | 4 years | |
| Erin Campany | F | 57 | 4 years | |
| Christopher Pierce | M | 44 | 2 years | |
| Elizabeth Keating | F | - | - | |
| Soon H. Lee | M | - | - | |
| Katie Cairati | F | - | - | |
| Richard Batycky | M | 56 | - | |
| Joseph T. Kennedy | M | 56 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Enrique Dilone | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Michael Rogers | M | 64 | 3 years | |
| Glenn Sblendorio | M | 68 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 years |
| Mary Fisher | F | 62 | 7 years | |
| Wise Young | M | 74 | 16 years | |
| Clare M. Carmichael | F | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Emmett Cunningham | M | 63 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Loni da Silva | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Martin Freed | M | 63 | 1 years | |
| Andrew Hindman | M | 51 | 5 years | |
| Sam Hall | M | 42 | 5 years | |
| Thomas C. Wessel | M | 68 | 3 years | |
| Barrett Katz | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Herbert Raymond Henney | M | - | 9 years | |
| Evelyn Harrison | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 6 years |
| Ruhi Khan | F | - | 5 years | |
| Christopher Carroll | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 1 years |
| Stephen Tulipano | M | 65 | 5 years | |
| Douglas Kargman | M | - | - | |
| Keith Westby | M | 49 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 87 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jennifer Burstein
- Personal Network